-
41.Mutant selectivity and combinations of a phosphoinositide 3-kinase inhibitor compound and chemotherapeutic agents for the treatment of cancer 有权
Title translation: 磷酸肌醇3-激酶抑制剂化合物的突变选择性和组合以及用于治疗癌症的化学治疗剂公开(公告)号:US09107926B2
公开(公告)日:2015-08-18
申请号:US13912281
申请日:2013-06-07
Applicant: Genentech, Inc.
Inventor: Marcia Belvin , Lori Friedman , Deepak Sampath , Jeffrey Wallin
IPC: C07D498/00 , C07D513/00 , A61K31/553 , A61K39/395 , A61K45/06 , A61K31/138 , A61K31/337 , A61K31/357 , A61K31/4196 , A61K31/437 , A61K31/4523 , A61K31/513 , A61K31/555 , A61K31/565 , A61K31/573 , A61K31/7068 , G01N33/50 , C12Q1/68 , C07K16/32
CPC classification number: A61K31/553 , A61K31/138 , A61K31/337 , A61K31/357 , A61K31/4196 , A61K31/437 , A61K31/4523 , A61K31/513 , A61K31/555 , A61K31/565 , A61K31/573 , A61K31/7068 , A61K39/39558 , A61K45/06 , C07K16/32 , C12Q1/6886 , C12Q2600/106 , C12Q2600/118 , C12Q2600/136 , C12Q2600/142 , C12Q2600/156 , C12Q2600/158 , G01N33/5011 , G01N33/5023 , A61K2300/00
Abstract: Methods and compositions are provided for treating hyperproliferative disorders in patients with a PI3K inhibitor, GDC-0032 as a single agent or in combination with chemotherapeutic agents.
Abstract translation: 提供了用于治疗患有PI3K抑制剂,GDC-0032作为单一药剂或与化学治疗剂组合的患者中的过度增殖性疾病的方法和组合物。